Researchers from The University of Texas MD Anderson Cancer Center reported promising results in a Phase I/II trial of 37 patients with relapsed or refractory B-cell malignancies who were treated with cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cell therapy targeting CD19.
Study helps explain how the brain adapts during a critical period of adulthood
Developing brains become shaped by the sights, sounds, and experiences of early life. The brain’s circuits grow more stable as we age.
October 5, 2023